Strathcona Resources Ltd (SCR.TO)

Revenue growth exceeding 1.5x Technology median of 6.02%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.

Gross profit growth exceeding 1.5x Technology median of 3.78%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.

EBIT growth of 295.49% while Technology median is zero. Walter Schloss would see a marginal edge that could be expanded upon.

Operating income growth of 295.49% while Technology median is zero. Walter Schloss might see a modest advantage that can expand.

Net income growth of 150.52% while Technology median is zero. Walter Schloss might see potential if moderate gains can keep rising.

EPS growth of 284.62% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.

Diluted EPS growth of 225.64% while Technology median is zero. Walter Schloss might see a slight edge that could improve over time.

OCF growth of 246.20% while Technology is zero. Walter Schloss might see a modest positive difference, which can compound over time.

FCF growth of 23.10% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.

10Y revenue/share CAGR exceeding 1.5x Technology median of 30.32%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.

5Y revenue/share growth exceeding 1.5x Technology median of 21.81%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.

3Y revenue/share growth exceeding 1.5x Technology median of 13.02%. Joel Greenblatt might see a short-term competitive advantage at play.

OCF/share CAGR of 1934.01% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.

OCF/share CAGR of 2670.37% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.

3Y OCF/share growth of 9202.19% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.

Net income/share CAGR exceeding 1.5x Technology median of 23.90% over a decade. Joel Greenblatt might see a standout compounder of earnings.

5Y net income/share CAGR > 1.5x Technology median of 20.24%. Joel Greenblatt might see superior mid-term capital allocation or product strength.

3Y net income/share CAGR > 1.5x Technology median of 10.69%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.

Equity/share CAGR exceeding 1.5x Technology median of 48.35% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.

5Y equity/share CAGR > 1.5x Technology median of 34.88%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.

3Y equity/share CAGR > 1.5x Technology median of 22.27%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.

No Data available this quarter, please select a different quarter.

Asset growth exceeding 1.5x Technology median of 1.52%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.

BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.

R&D dropping while Technology median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.

SG&A decline while Technology grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.